USA CON Nurse Education, Practice, Quality and Retention Mobile Health Training (REEACH) ECHO®

Attention Healthcare Providers – If your patients benefit from comprehensive integrated healthcare, from local people they know and trust, then the USA CON REEACH ECHO® program can provide you with interprofessional telementoring.
No cost to participate | Free continuing education credits available to eligible participants.
Mission
In response to national health professional shortages, Colleges of Nursing, Medicine, and Allied Health around the country have increased enrollment. Often, nursing students emerge from nursing education programs inadequately prepared to understand the consequences of social determinants of health (SDOH) and the importance of providing safe and equitable care across diverse populations. Concurrently, the COVID-19 pandemic has decreased the volume of clinical training opportunities due to initial safety concerns and ongoing staff shortages. The REEACH nurse training program addresses the need for an enhanced didactic curriculum related to SDOH and health equity concepts for current students and through the USA CON REEACH ECHO® program outreaches to the community nurse and healthcare worker.
USA CON REEACH Nurse Training Program
REEACH is designed to provide longitudinal experiential training experiences for RN-to-BSN and APRN students in rural and underserved communities through clinical experiences on nurse-led mobile health units. For more information on this training program, visit the REEACH Program web page.
USA CON REEACH ECHO® Purpose
To bring healthcare professionals together in a virtual learning environment where collaboration and connection with subject matter experts will increase the community-based learning and collaboration to improve health equity and impact SDOH using a comprehensive approach to provide culturally aligned care in rural and underserved communities through nurse-led interprofessional teams
Our ECHO® programming consists of the following:
- A Zoom session (9 monthly sessions)
- A short lecture provided by subject matter experts
- A case scenario presentation and discussion
- Questions, discussion, and engagement with other providers and experts

Launch Date: TBA 2023
Session Dates
Year 2023 - 2024
TBA – Monthly for 9 sessions
This USA CON REEACH ECHO® series will consist of nine (9) sessions. All sessions are 90 minutes, from 12:00 p.m. until 1:30 p.m., Central Time.
Session | Date | Topic |
---|---|---|
Session 1 |
July 2023*
|
TBA |
Session 2 | August 2023* | TBA |
Session 3 | September 2023* | TBA |
Session 4 | October 2023* | TBA |
Session 5 | February 2024* | TBA |
Session 6 | March 2024* | TBA |
Session 7 | April 2024* | TBA |
Session 8 | May 2024* | TBA |
Session 9 | June 2024* | TBA |
*Dates TBA
To Join
To join the USA CON REEACH ECHO®, please complete the Pre-registration Survey Form (link below). Upon completion of this pre-registration, you will automatically receive the sessions’ Registration Survey Form for the nine (9) interactive, ninety (90) minute Zoom sessions to be scheduled during 2023.
The Pre-registration Survey Link will be available soon; please check back. You can also email us at reeachecho@southalabama.edu to be placed on a waiting list.
Project ECHO®: The University of South Alabama collects registration, participation, questions/answers, chat comments, and poll responses for ECHO® programs. Your individual data will be kept confidential. These data may be used for reports, maps, communications, surveys, quality assurance, evaluation, research, and to inform new initiatives.
Registration will remain open during the series period.
Questions? Email us - USA CON REEACH ECHO® - at reeachecho@southalabama.edu.
The USA CON REEACH ECHO® is funded by Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling approximately $3.6 million, with zero percentage financed by nongovernmental sources. The contents are those of the author and do not necessarily represent the official view of nor an endorsement of HRSA, HHS, or the U.S. government.